Correlation Between Catalyst Pharmaceuticals and Denarius Silver

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Denarius Silver at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Denarius Silver into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Denarius Silver Corp, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Denarius Silver and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Denarius Silver. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Denarius Silver.

Diversification Opportunities for Catalyst Pharmaceuticals and Denarius Silver

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Catalyst and Denarius is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Denarius Silver Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denarius Silver Corp and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Denarius Silver. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denarius Silver Corp has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Denarius Silver go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Denarius Silver

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.74 times more return on investment than Denarius Silver. However, Catalyst Pharmaceuticals is 1.34 times less risky than Denarius Silver. It trades about 0.07 of its potential returns per unit of risk. Denarius Silver Corp is currently generating about 0.03 per unit of risk. If you would invest  2,152  in Catalyst Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of  104.00  from holding Catalyst Pharmaceuticals or generate 4.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Denarius Silver Corp

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Denarius Silver Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denarius Silver Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Catalyst Pharmaceuticals and Denarius Silver Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Denarius Silver

The main advantage of trading using opposite Catalyst Pharmaceuticals and Denarius Silver positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Denarius Silver can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denarius Silver will offset losses from the drop in Denarius Silver's long position.
The idea behind Catalyst Pharmaceuticals and Denarius Silver Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk